Clinical Research Directory

Inclusion Criteria: The following criteria must be met for subjects to be eligible for inclusion into the study * Subjects indicated for the treatment of paroxysmal AF with the RF ablation system according to current and future Guidelines and system indications for use * Subjects who are willing and capable of providing informed consent * Patients who have stopped amiodarone for at least one month * Subjects whose age is \> 18 years old * Subjects whose age is \< 80 years old * Subjects who are willing and capable of participating in all testing associated with this clinical study at an approved clinical investigational center Exclusion Criteria: Subjects who meet any one of the following criteria will be excluded from this clinical study * Patients who had already undergo an AF ablation procedure * Any known contraindication to an AF ablation or anticoagulation, including those listed in the instructions for use * Subjects with indication for treatment of AF that is not according to current and future Guidelines and system indications for use * Presence of an intracavitary thrombus * Subjects that are unable or not willing to complete follow-up visits and examination for the duration of the study * Patients with left ventricular ejection fraction \< 35% * Women of childbearing potential who are, or plan to become, pregnant during the time of the study (method of assessment upon investigator's discretion) * Hematological contraindications to ionizing radiation exposure * Presence of complex congenital heart disease, and cardiac surgery within 1 month from enrollment * Uncontrolled heart failure * Subjects with severe valvular disease OR with a prosthetic - mechanical or biological- heart valve (not including valve repair and annular rings) * Contraindications to general anesthesia * Subjects who are currently enrolled in another investigational study or registry that would directly interfere with the current study